“Glycemic Outcomes Of Dapagliflozin, Glimepiride, And Sitagliptin As Add-On Therapy To Metformin In Patients With Type 2 Diabetes Mellitus: A Prospective Observational Study”, Rev Diabet Stud, pp. 693–700, Sep. 2025, doi: 10.70082/qs5vrk14.